JANX

Janux Therapeutics (JANX)

About Janux Therapeutics (JANX)

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Details

Daily high

$15.28

Daily low

$13.46

Price at open

$13.79

52 Week High

$47.58

52 Week Low

$12.80

Market cap

798.2M

Dividend yield

0.00%

Volume

6.2M

Avg. volume

1.6M

P/E ratio

-7.92

Janux Therapeutics News